Bayer AG's CEO, Bill Anderson, asserts that India's intellectual prowess and technological leadership could make it a global leader in biomedical innovation.

(Reuters) - German drugmaker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the country's Supreme Court ruled against ...

Bayer launched its cancer drug, Nubeqa which received approval in India for an expanded indication, offering clinicians access to a non-chemotherapy treatment option for patients who may not be able ...

(AP) India’s patent appeals office has rejected Bayer AG’s plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important ...

Sept 17 (Reuters) - An Indian patents appeals board on Friday dismissed Bayer AG's petition seeking a stay on the "compulsory license" issued to India's Natco Pharma for selling generic copies of ...